1. Adler AI, Stevens RJ, Manley SE, Bilous RW, Cull CA, Holman RR, UKPDS GROUP. Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 2003;63:225–32.
2. Agarwal S, Sandeep KB, Anuradha R, Vasudha K, Chadha KH, Doli P, et al. Microalbuminuria. Clin Lab Technol. 2002;3(1):14–22.
3. American Diabetes Association. Standards of medical care in diabetes—2014. Diabetes Care 2014;37:S14–S80.
4. Apperloo AJ, de Zeeuw D, de Jong PE. Short-term antiproteinuric response to antihypertensive treatment predicts long-term GFR decline in patients with non-diabetic renal disease. Kidney Int Suppl. 1994;45:S174–8.
5. Araki S, Haneda M, Koya D, et al. Reduction in albuminuria as an integrated indicator for renal and cardiovascular risk reduction in patients with type 2 diabetes. Diabetes. 2007;56:1727–30.